Drugs of abuse: teratogenic and mutagenic considerations
Evans, M.A.; Stevens, M.W.; Mantilla-Plata, B.; Harbison, R.D.
Addictive Diseases 2(1-2): 45-61
1975
ISSN/ISBN: 0094-0267 PMID: 1163373 Document Number: 91253
Document emailed within 1 workday
Related Documents
Aoun, E.G.; Christopher, P.P.; Ingraham, J.W. 2014: Emerging drugs of abuse: clinical and legal considerations Rhode Island Medical Journal 97(6): 41-45Czeizel, E.; Trabert, G. 1988: Teratogenic and mutagenic effect of ionizing radiation Orvosi Hetilap 129(37): 1979-1981
Lafontaine, A.; Aerts, J.; Jacques, P. 1981: Toxicity, carcinogenic, mutagenic, teratogenic action of dichlorvos Archives Belges de Medecine Sociale Hygiene Medecine du Travail et Medecine Legale. Belgisch Archief van Sociale Geneeskunde Hygiene Arbeidsgeneeskunde en Gerechtelijke Geneeskunde 39(3): 159-174
Marczinski-Verheugt, E.; Doerfler, W. 1978: Mutagenic and teratogenic effects of cigarette smoke. A summary of experimental and clinical observations Münchener Medizinische Wochenschrift 120(10): 327-330
Caratzali, A.; Roman, I.C. 1975: Possible teratogenic effects of some drugs Morphologie et Embryologie 21(2): 129-133
Ramzin, M.S. 1982: Teratogenic effect of drugs Der Gynakologe 15(3): 136-142
Canfield, P.R. 1978: Teratogenic effects of drugs during pregnancy Journal of Family Practice 6(1): 26; 30
Cahen, R.; Fave, A. 1970: Is there a relation between the teratogenic effect and transplacental passage of drugs? Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 164(3): 610-616
Campistol, J. 2002: Teratogenic effects of epilepsy and anti epileptic drugs Revista de Neurologia 35(Suppl 1): S135-S143
Richards, I.D. 1972: A retrospective enquiry into possible teratogenic effects of drugs in pregnancy Advances in Experimental Medicine and Biology 27: 441-455
Farkas, G.; Farkas, G. 1971: Teratogenic effects of hyperemesis gravidarum and of the customary drugs used in its therapy Zentralblatt für Gynakologie 93(10): 325-330
Maresova, V.; Chadt, J.; Novakova, E. 2008: Screening and semiquantitative analysis of drugs and drugs of abuse in human serum samples using gas chromatography-mass spectrometry Neuro Endocrinology Letters 29(5): 749-754
Allen, L.V. 1995: Drugs, devices and delivery considerations in parenteral pharmaceutical care, or, what are they doing with our drugs? PDA Journal of Pharmaceutical Science and Technology 49(6): 306-308
Jönsson, N.A.; Mikiver, L.; Selberg, U. 1972: Chemical structure and teratogenic properties. II. Synthesis and teratogenic activity in rabbits of some derivatives of phthalmide, isoindoline-1-one, 1,2-benzisothiazoline-3-one-1,1-dioxide and 4(3H)-quinazolinone Acta Pharmaceutica Suecica 9(5): 431-446
Fennelly, J.J. 1971: Drugs and their abuse no. V--misuse of cytotoxic drugs Journal of the Irish Medical Association 64(416): 383-384
Cohen, M.; Levin, S.H.; Gagin, R.; Friedman, G. 2007: Elder abuse: disparities between older people's disclosure of abuse, evident signs of abuse, and high risk of abuse Journal of the American Geriatrics Society 55(8): 1224-1230
Ungváry, G. 1985: The possible contribution of industrial chemicals (organic solvents) to the incidence of congenital defects caused by teratogenic drugs and consumer goods--an experimental study Progress in Clinical and Biological Research 163b: 295-300
Lynch, T. 1971: Drugs and their abuse. IV. Sedative drugs Journal of the Irish Medical Association 64(415): 357-358
Wurmser, L. 1973: Psychosocial aspects of drug abuse. 1. Etiological considerations Maryland State Medical Journal 22(7): 78-82
Paci, A.; Migliaccio, P.; Paci, G. 1999: Occult child abuse (opinions, considerations, personal observations) La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics 21(6): 249-253